SMAC Mimetic BV6 Co-Treatment Downregulates the Factors Involved in Resistance and Relapse of Cancer: IAPs and Autophagy
Cancer is the utmost common disease-causing death worldwide, characterized by uncontrollable cell division with the potential of metastasis. Overexpression of the Inhibitors of Apoptosis proteins (IAPs) and autophagy correlates with tumorigenesis, therapeutic resistance, and reoccurrence after antic...
Main Authors: | Sahar Rafat, Prabhakar Singh, Kamlesh Kumar Pandey, Saleh A. Almatroodi, Mohammed A. Alsahli, Ahmad Almatroudi, Arshad Husain Rahmani, Kapil Dev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/11/1581 |
Similar Items
-
Future Therapeutic Directions for Smac-Mimetics
by: Emma Morrish, et al.
Published: (2020-02-01) -
The SMAC mimetic AT-101 exhibits anti-tumor and anti-metastasis activity in lung adenocarcinoma cells by the IAPs/ caspase-dependent apoptosis and p65-NFƙB cross-talk
by: Irfan Ahmad, et al.
Published: (2021-07-01) -
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
by: Tanmay M. Shekhar, et al.
Published: (2019-09-01) -
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling
by: Yusuke Shibuya, et al.
Published: (2023-02-01) -
Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
by: Nevine M.Y. Elsayed, et al.
Published: (2015-06-01)